# Stoboclo

NDC: 72606-037
Generic name: denosumab-bmwo
Labeler / Manufacturer: CELLTRION USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250702

FDA application: BLA761404

## Active ingredients

- DENOSUMAB: 60 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-037"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-037
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10b9eea3-bf70-4ff3-a0b9-54248cbfd156